Organigram CEO warns of unsustainably cheap cannabis, reports CA$7.5M quarterly loss

April 13, 2023 · MJ Biz Daily

The CEO of Canadian producer Organigram Holdings is warning about heavily discounted marijuana in the nation’s recreational market, saying that ultra-low prices are “not sustainable and (hurt) the cannabis industry.”

The company’s chief executive, Beena Goldenberg, said on a Wednesday quarterly earnings call that, although “many producers have discussed not wanting to participate in a race to the bottom, we are seeing the opposite in the market.”

Goldenberg said large, 28-gram cannabis flower packages retailing for less than 100 Canadian dollars (roughly $75) have “increased by almost 300% over the past six months.”

“Large-format pricing in some markets has reached the point that, considering the cost of production and the excise tax burden, the products are being sold at a loss.”

Goldenberg added that Organigram’s “low-cost structure allows us to compete at these reduced prices” but said the Toronto-based company has “not matched the aggressiveness of our competitors and have seen some market share erosion in our large-format flower.”

Later in the call, Goldenberg said Organigram would continue competing in the large-format flower segment, “but we just won’t compete at the very low prices, it’s just not sustainable.”

The cannabis executive’s comments came as Organigram reported a net loss of CA$7.5 million for the quarter ended Feb. 28, as net revenue grew 24% from the same quarter last year to CA$39.5 million.

The company’s net loss increased 85% compared to the second quarter of 2022, with Organigram attributing that increased net loss to “to the change in fair value of derivative warrant liabilities.”

In its previous quarter, Organigram reported a net profit of CA$5.3 million.

Goldenberg said the second quarter is typically Organigram’s lowest for sales due to seasonality, with sales peaking during the summertime fourth quarter.

Organigram’s chief financial officer, Derrick West, said on the call that Organigram expects “to generate positive free cash flow by the end of calendar (year) 2023.”

Organigram claimed the No. 3 spot among licensed Canadian cannabis producers, with leading positions in pre-ground flower and hashish and a third-place spot in gummies.

CEO Goldenberg said Organigram is “underdeveloped” in the vape segment compared to its competitors.

However, she expressed optimism that Organigram’s recent CA$4 million investment in vape hardware company Greentank – which comes with an exclusivity period for Organigram to use the Toronto-headquartered businesses’ upcoming technology in Canada – will help differentiate her company’s vape products in the future.

Goldenberg said the pending vape hardware “doesn’t have the partially cooked oil that saturates the old ceramic coils, that causes the clogging and leaks and the unpleasant flavor.”

Meanwhile, Organigram is fighting back against a regulatory decision that puts another product segment at risk.

Health Canada recently asked Organigram to stop selling its Edison Jolts cannabis lozenges, which contain 100 milligrams of THC per package, over concerns that the products are misclassified as cannabis extracts rather than edibles.

Goldenberg said Organigram can keep selling the products through May 31 and “(remains) of the view that the patent-pending Jolts are properly classified as cannabis extracts and compliant with cannabis regulations.”

She said Organigram has “filed an application with the Federal Court of Canada seeking judicial review of Health Canada’s determination.”

“As court proceedings can take some time, we intend to file a motion for a stay, seeking to set aside the decision in the interim.” (Full Story)

In category:International
Next Post

Germany Scales Back Its Cannabis Legalization Plan

German officials have announced they are scaling back their widely anticipated cannabis legalization plan following a discussion with European Union officials, the Associated Press reports. The new plan, revealed on Wednesday, is to legalize cannabis possession of up to 25 grams and establish nonprofit…
Previous Post

Canadian cannabis producer Phoena winds-down business, blames high taxes

Canadian cannabis producer Phoena Group has been granted creditor protection and is winding down its operations, the company said in court documents. The Vaughan, Ontario-based company – formerly called CannTrust – said it no longer has the financial footing to…
Random Post

Marijuana companies wade into Twitter advertising with mixed success

It didn’t take long for the first marijuana advertisements on Twitter to get shut down. On the first day the social media platform accepted cannabis ads in February, Hemper Co. Chief Marketing Officer Angel Ferrer set up an account and…
Random Post

Chris Christie Vows To ‘End’ The Drug War If Elected President—But Only Partially

Former New Jersey Gov. Chris Christie (R), a Republican 2024 presidential candidate, says that he would “end” the war on drugs if elected, emphasizing the need for a treatment-based approach to people experiencing addiction—while at the same time maintaining that he’d…
Random Post

Once a marijuana enemy, DEA now key to rescheduling

The most significant shift in U.S. marijuana policy is drawing closer, but one major obstacle remains in reform’s way: the Drug Enforcement Administration. On Aug. 29, the U.S. Department of Health and Human Services (HHS) responded to President Joe Biden’s…
Random Post

Hunter Biden’s Attorneys Cite Marijuana And Gun Ruling To Deter Charges On Alleged Federal Form Lying, Reports Say

Attorneys for President Joe Biden’s son reportedly told Justice Department officials that a recent federal court ruling on gun rights for people who use marijuana should invalidate any charges related to allegations that he lied about his drug use on…